Literature DB >> 11858984

Quality assurance in medical oncology within the EORTC. European Organisation for Research and Treatment of Cancer.

P Therasse1, P H M De Mulder.   

Abstract

Quality assurance (QA) lately arrived in the medical arena in comparison to other fields. EORTC focused initially its attention on the aspects related to clinical trial data handling. In the late 1980s, the EORTC appointed a Quality Control Committee (QCC) with the remit to expand the QA activities to the main disciplines involved in cancer treatment. From 1990 to 1996, two projects supported by the European Commission enabled the QCC to address, amongst others, specific questions related to medical oncology. Both projects focused on the practices of chemotherapy delivery and the quality of data reporting. Following these projects, the QCC developed standard guidelines to advise on chemotherapy delivery and also a systemic chemotherapy checklist to enable an easy collection of essential data onto the patient's files. More recently, the EORTC QA Committee proposed a minimal set of quality control procedures to be implemented by all EORTC groups.

Entities:  

Mesh:

Year:  2002        PMID: 11858984     DOI: 10.1016/s0959-8049(01)00437-3

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  1 in total

Review 1.  Quality Assurance and Improvement in Head and Neck Cancer Surgery: From Clinical Trials to National Healthcare Initiatives.

Authors:  Christian Simon; Carmela Caballero
Journal:  Curr Treat Options Oncol       Date:  2018-05-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.